India's Natco Pharma plunges on weak quarterly earnings

Natco Pharma

13/02/2025 04:21

** Shares of India's Natco Pharma  NATP.NS  drop 16.5% to
1017 rupees, marking their biggest intraday loss since debut 
    ** The drugmaker's Q3 consol net profit fell 37.5% y/y,
while rev dropped 37.4% y/y
    ** Stock sees steepest fall since June 5, 2024, set for
fifth straight session of losses, if current trend holds 
    ** NATP stock has lost ~27% so far in 2025

 (Reporting by Yagnoseni Das in Bengaluru)
 ((Yagnoseni.Das@thomsonreuters.com;))